ANI Pharmaceuticals (ANIP) to Post Q1 Earnings: What's in Store?
ANI Pharmaceuticals(ANIP) Zacks Investment Research·2024-05-06 16:31ANI Pharmaceuticals (ANIP) is slated to report first-quarter 2024 results on May 10, before the opening bell. Investors are advised to focus on the sales performance of the company’s core business segments — rare disease and generic business.The Zacks Consensus Estimate for the company’s earnings per share is currently pegged at 98 cents. The Zacks Consensus Estimate for total revenues is pinned at $125 million.Let's see how things might have shaped up for the upcoming quarterly release.Factors to ConsiderA ...